A multiple dose, pharmacokinetic study comparing different regimens of testosterone given as intranasal Nasobol in hypogonadal men in comparison to testosterone levels in normal healthy male volunteers
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2018
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Mattern Pharmaceuticals
- 03 Apr 2018 Last checked against ClinicalTrials.gov record.
- 29 Mar 2018 Phase 2 has been changed to phase 1.
- 03 May 2012 Actual patient number added 32 according to ClinicalTrials.gov.